26 filings · most recent first
PFE 8-K Filings
Pfizer Reaffirms Fiscal Year 2026 Guidance
Pfizer Announces Cfo Transition
Pfizer Announces First Quarter 2026 Financial Results
Pfizer Inc Announces Election Results From Annual Meeting Of Shareholders
Pfizer Announces Fourth Quarter 2025 Financial Results
Pfizer Inc Completes Public Offering Of Various Notes
Pfizer Inc Subsidiary Completes 33 Billion Debt Offering
Pfizer Provides Fullyear 2026 Guidance And Revises 2025 Revenue Forecast
Pfizer Completes Acquisition Of Metsera Inc
Pfizer Announces Third Quarter 2025 Financial Results
Pfizer Announces Second Quarter 2025 Financial Results
Pfizer Announces First Quarter 2025 Financial Results And Expanded Cost
Pfizer Inc Announces Results Of Annual Meeting Of Shareholders
Pfizer Announces 2024 Fullyear And Fourthquarter Financial Results
Pfizer Provides Fullyear 2025 Guidance And Reaffirms 2024 Guidance
Pfizer Inc Announces Third Quarter 2024 Financial Results
Pfizer Inc Elects Tim Buckley To Board Of Directors
Pfizer Reports Second Quarter 2024 Financial Results
Pfizer Extends Longterm Incentive Grants For Employee Retention
Pfizer Announces Beginning Of Search For New Chief Scientific Officer
Pfizer Appoints Cyrus Taraporevala To Board Of Directors
Pfizer Announces Multiyear Cost Reduction Program
Pfizer Announces First Quarter 2024 Financial Results
Pfizer Annual Meeting Voting Results
Pfizer Announces Fourthquarter And Fullyear 2023 Financial Results
Pfizer Issues Warning Against Trc Capitals Belowmarket Minitender Offer